dehydroepiandrosterone sulfate and Colitis, Granulomatous

dehydroepiandrosterone sulfate has been researched along with Colitis, Granulomatous in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ananthakrishnan, AN; Chan, AT; Fuchs, CS; Hankinson, SE; Higuchi, LM; Khalili, H; Konijeti, GG; Richter, JM; Tworoger, SS	1
Folwaczny, C; Siveke, JT	1
Andus, T; Gross, V; Lang, B; Schölmerich, J; Straub, RH; Vogl, D	1

Reviews

1 review(s) available for dehydroepiandrosterone sulfate and Colitis, Granulomatous

Article	Year
Biological response modifiers for the treatment of Crohn's disease. Expert opinion on biological therapy, 2004, Volume: 4, Issue:11 Topics: Animals; Antibodies, Monoclonal; Cell Adhesion; Cell Adhesion Molecules; Clinical Trials, Phase III as Topic; Crohn Disease; Cytokines; Dehydroepiandrosterone Sulfate; Drug Evaluation, Preclinical; Growth Substances; Humans; Immunologic Factors; Immunosuppressive Agents; Lymphocyte Activation; Mice; Randomized Controlled Trials as Topic; Remission Induction; T-Lymphocytes; Tumor Necrosis Factor-alpha	2004

Article

Year

Biological response modifiers for the treatment of Crohn's disease.

Expert opinion on biological therapy, 2004, Volume: 4, Issue:11

Topics: Animals; Antibodies, Monoclonal; Cell Adhesion; Cell Adhesion Molecules; Clinical Trials, Phase III as Topic; Crohn Disease; Cytokines; Dehydroepiandrosterone Sulfate; Drug Evaluation, Preclinical; Growth Substances; Humans; Immunologic Factors; Immunosuppressive Agents; Lymphocyte Activation; Mice; Randomized Controlled Trials as Topic; Remission Induction; T-Lymphocytes; Tumor Necrosis Factor-alpha

2004

Other Studies

2 other study(ies) available for dehydroepiandrosterone sulfate and Colitis, Granulomatous

Article	Year
Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts. Inflammatory bowel diseases, 2015, Volume: 21, Issue:6 Topics: Adult; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Dehydroepiandrosterone Sulfate; Female; Humans; Logistic Models; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Testosterone; United States	2015
Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. The American journal of gastroenterology, 1998, Volume: 93, Issue:11 Topics: Adolescent; Adult; Blood Sedimentation; C-Reactive Protein; Cell Adhesion Molecules; Colitis, Ulcerative; Crohn Disease; Dehydroepiandrosterone Sulfate; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydrocortisone; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-6; Male; Middle Aged; Receptors, Interleukin-1; Receptors, Interleukin-2; Tumor Necrosis Factor-alpha	1998

Article

Year

Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts.

Inflammatory bowel diseases, 2015, Volume: 21, Issue:6

Topics: Adult; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Dehydroepiandrosterone Sulfate; Female; Humans; Logistic Models; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Testosterone; United States

2015

Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.

The American journal of gastroenterology, 1998, Volume: 93, Issue:11

Topics: Adolescent; Adult; Blood Sedimentation; C-Reactive Protein; Cell Adhesion Molecules; Colitis, Ulcerative; Crohn Disease; Dehydroepiandrosterone Sulfate; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydrocortisone; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-6; Male; Middle Aged; Receptors, Interleukin-1; Receptors, Interleukin-2; Tumor Necrosis Factor-alpha

1998